José Ramón Santos

Immunogenicity and reactogenicity of BNT162b2 booster in ChAdOx1-S-primed participants (CombiVacS): a multicentre, open-label, randomised, controlled, phase 2 trial

Alberto M. Borobia, Antonio J. Carcas, Mayte Pérez‐Olmeda et al. · The Lancet · 2021 · 384 citations · Full text

Nadir CD4 T Cell Count as Predictor and High CD4 T Cell Intrinsic Apoptosis as Final Mechanism of Poor CD4 T Cell Recovery in Virologically Suppressed HIV‐Infected Patients: Clinical Implications

Eugènia Negredo, Marta Massanella, Jordi Puig et al. · Clinical Infectious Diseases · 2010 · 148 citations · Full text

The Lipid-Lowering Effect of Tenofovir/Emtricitabine: A Randomized, Crossover, Double-Blind, Placebo-Controlled Trial

José Ramón Santos, María Saumoy, Adrián Curran et al. · Clinical Infectious Diseases · 2015 · 136 citations · Full text

Determinants of the onset and prognosis of the post-COVID-19 condition: a 2-year prospective observational cohort study

Lourdes Mateu, Cristian Tebé, Cora Loste et al. · The Lancet Regional Health - Europe · 2023 · 107 citations · Full text

Influence of HAART on the Clinical Course of HIV-1-Infected Patients With Progressive Multifocal Leukoencephalopathy: Results of an Observational Multicenter Study

Vicenç Falcó, Montserrat Olmo, S Villar del Saz et al. · JAIDS Journal of Acquired Immune Deficiency Syndromes · 2008 · 93 citations